SEC CIK 1297709

Novartis Bioventures Ltd

Reported ownership across 11 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
ALTview stock →8,345,1452018-09-12
NONEview stock →5,245,5502017-03-15
ARPOview stock →4,049,8042019-04-26
AKBAview stock →3,405,7642014-03-25
MRNAview stock →2,899,0702010-07-21
GRTXview stock →2,467,9612020-06-19
ALRNview stock →2,079,3942019-04-01
NASDAQ:ALTview stock →1,867,3012017-05-04
BCYCview stock →1,769,6412019-05-28
AKUSview stock →1,181,2582020-06-30
FMTXview stock →331,2212020-06-18

Position History — BCYC

Reported shares owned immediately after each Form 4 transaction, over time.

0589,8801,179,7611,769,6412019-052019-052019-052019-05

Recent Filings — BCYC

DateActivitySharesPriceOwned After
2019-05-28Conversion (derivative)636,366—0
2019-05-28Option exercise (out-of-money) (derivative)71,450—0
2019-05-28Conversion (derivative)893,195—0
2019-05-28Open-market buy168,630$14.001,769,641
2019-05-28Conversion636,366—1,601,011
2019-05-28Option exercise (out-of-money)71,450—964,645
2019-05-28Conversion893,195—893,195

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.